NCT03926507View on ClinicalTrials.gov

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

September 18, 2023

Study Completion Date

September 18, 2023

Conditions
Glioblastoma
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT scan

OTHER

Fluciclovine F18

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT scan

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03926507 - F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery | Biotech Hunter | Biotech Hunter